Skip to content

Development of Imaging Techniques for HIV-1 Cell-Cell Contacts and T-cells

· 0 citations · 42 references

TL;DR

A robust cell-cell contact imaging assay is established with T-cells and monocyte-like macrophage and an orthogonal approach to the biochemical verification for the chimera’s monomeric nature is provided.

Abstract

Human Immunodeficiency Virus 1 (HIV-1) became a global pandemic in the early 1980s, continuing to affect millions of people every year. Though progress has been made in the last four decades, there are no FDA approved therapeutic classes for the assembly stage in the HIV-1 replication cycle. Previous studies have found the HIV-1 can become drug resistant by increasing its prevalence to infect naïve cells by cell-cell contact. Therefore, it is more important now than ever to study the spread of HIV-1 from cell-cell contacts. First, we establish a robust cell-cell contact imaging assay with T-cells and monocyte-like macrophage (MLM). We, then, combine this pulse-chase assays to investigate the mobility of internalized Env to sites of cell-cell contact and determine that exocytosis to these sites was not seen on a large or readily rapid rate. Next, we combined our established cell-cell contact system with lithography masks and hydrophobic compound Lipidure to only allow cells to lay down on areas of the imaging coverslip that were ablated. This was used for adherent immune cells as well as improved upon to establish an imaging method for suspension T-cells. We found an increase in the number of cell-cell contacts with our method. Following this, we use single channel superresolution microscopy to quantify the relative monomeric and dimeric CD4 population. Here, we provided an orthogonal approach to the biochemical verification for the chimera’s monomeric nature. Lastly, we use simultaneous, dual-color superresolution imaging to investigate the nanometer organization of viral proteins and receptors at sites of cell-cell contact.

View source

Similar papers

Open access Aug 2026

A new HIV-1 latency reversing agent activating HIV-Tat

D10 is the first Tat activator available and the first LRA that targets an HIV protein, and induces strong HIV production by latent cell lines and latent cells from people living with HIV-1.

P. Tong, Laetitia Marty, Nawel Chekrit et al. · 0 citations
Open access

Inhibitors screeing against HIV-1 Nef-mediated MHC-I

Human immunodeficiency virus type 1 (HIV-1) remains a major global health challenge. Although current treatments effectively suppress viral replication, they are unable to eliminate infected cells. The viral accessory protein Nef contributes substantially to HIV-1 persistence: it downregulates multiple host immune rece...

Ke-Quan Wang · 0 citations
Open access Aug 2026

Sensitive detection of rare HIV-infected cells in the human brain by single-nucleus RNA sequencing

A scalable multi-reference framework for detecting HIV RNA–positive cells in human CNS single-nucleus RNA-seq data is presented and provides large-scale quantitative evidence that microglia represent the dominant and most persistent HIV-infected population in the human brain.

Yuan-Yuan Cai, Nicholas C. Jacobs, Dana Gabuzda et al. · 0 citations

Biophysical Investigation into the Mechanisms Regulating HIV-1 Envelope Glycoprotein Incorporation

Human Immunodeficiency Virus type-1 (HIV-1) infects CD4+ T cells and remains a global pandemic due to our incomplete understanding of the molecular mechanisms underlying its highly coordinated and regulated assembly process and the strategies it uses for immune evasion. For HIV-1 to produce infectious particles, the vi...

Austin R. Clark · 0 citations
Open access

Characterization of a CRISPR/Cas9-based molecular recorder for HIV-1

HIV-SCRIBE is developed, a CRISPR-based molecular recorder in which a self-targeting guide RNA locus is placed under a Tat-responsive minimal HIV-1 5'LTR promoter, coupling Cas9-mediated cleavage and error-prone repair to Tat-driven transcriptional activation to generate a durable molecular record of HIV-1 reactivation...

Nahia Urturi Ortiz, M. Nonnemacher, Brian Wigdahl · 0 citations
Review Open access Sep 2026

Molecular mechanisms of HIV-1 entry into host cells and emerging therapeutic strategies

This review synthesizes current biochemical and structural insights into HIV-1 entry, with emphasis on envelope conformational dynamics, receptor and co-receptor interactions, membrane fusion mechanisms, and host determinants that regulate entry efficiency and tropism.

Lamarana Jallow, P. Quashie · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.